Investors

2016 Press Releases

Keyword Search
 
2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006
September 06, 2016
Codexis to Present at September Investment Conferences
REDWOOD CITY, Calif., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at three upcoming investment conferences: Rodman & Renshaw 18th Annual Global Investment Conference on Monday, September 12, 2016, at 5:05 p.m. Eastern time (2:05 p.m. Pacific time). The conference is being held at the New York Palace Hotel in New York City. 2016 KeyBanc Capital Markets’ Basic Materials & Packa... 
August 09, 2016
Codexis Reports Financial Results for the Second Quarter of 2016
Net income reaches $2.2 million; revenues of $16.0 million include milestone payments from GSK and a major biopharmaceutical company, and 62% growth in core biocatalyst product sales Conference call begins at 4:30 p.m. Eastern time today REDWOOD CITY, Calif., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces financial results for the three and six months ended June 30, 2016, and provides a business update. “We are reporting outst... 
August 02, 2016
Codexis to Hold 2016 Second Quarter Conference Call on August 9
REDWOOD CITY, Calif., Aug. 02, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report second quarter 2016 financial results after market close on Tuesday, August 9, 2016.  Codexis management will hold an investment community conference call at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss financial results and provide a company update.  Live Call: U.S. 855 890 8665   Intern... 
July 28, 2016
Codexis Completes Obligations Under Research and Development Agreement with Leading Biopharmaceutical Company
Enzyme developed with CodeEvolver® technology for preclinical therapeutics program exceeds agreement requirements REDWOOD CITY, Calif., July 28, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces the successful completion of its obligations under a collaborative research and development agreement with a leading global biopharmaceutical company.  Under the agreement, Codexis employed its CodeEvolver® protein engineering platform technology to... 
June 02, 2016
Codexis to Present at Jefferies 2016 Healthcare Conference
REDWOOD CITY, Calif., June 02, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that President and CEO John Nicols and Senior Vice President and CFO Gordon Sangster will present at the Jefferies 2016 Healthcare Conference on Friday, June 10th, at 2:00 p.m. Eastern time (11:00 a.m. Pacific time).  The conference is being held in New York City.    A live webcast and replay will be available on the Investors section of the company's website... 
May 18, 2016
Codexis to Present at Upcoming Investment Conferences
REDWOOD CITY, Calif., May 18, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at two upcoming investment conferences: 17th Annual B. Riley Investor Conference on May 25, 2016, at 9:30 a.m. Pacific time (12:30 p.m. Eastern time). The conference is being held at the Loews Hollywood Hotel in Los Angeles.   13th Annual Craig-Hallum Institutional 1x1 Investor Conference on June 1, 2016 at The Depot Renai... 
May 09, 2016
Codexis Reports Financial Results for the First Quarter of 2016
Revenues increase 18% to $8.0 million on significant growth in core biocatalyst R&D revenues and product sales Conference call begins at 4:30 p.m. Eastern time today REDWOOD CITY, Calif., May 09, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces financial results for the three months ended March 31, 2016, and provides a business update. “Codexis is off to a very solid start for 2016 delivering $8 million in revenues for the first qu... 
May 02, 2016
Codexis to Hold 2016 First Quarter Conference Call on May 9
REDWOOD CITY, Calif., May 02, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report first quarter 2016 financial results after market close on Monday, May 9, 2016.  Codexis management will hold an investment community conference call at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss financial results and provide a company update.  Live Call: U.S. 855 890 8665   Internationa... 
May 02, 2016
Codexis Completes CodeEvolver® Technology Transfer to GSK; Earns $7.5 Million Milestone Payment
REDWOOD CITY, Calif., May 02, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces the completion of the third and final Wave in the transfer of its proprietary CodeEvolver® protein engineering platform technology to GlaxoSmithKline (GSK).  Codexis expects to receive a $7.5 million payment from GSK for completion of this milestone in the second quarter of 2016. “We are delighted to have successfully completed the first full transfer of our C... 
March 03, 2016
Codexis Reports 2015 Fourth Quarter and Full Year Financial Results
Meets 2015 Financial Guidance and Introduces 2016 Financial Guidance Conference call begins at 4:30 p.m. Eastern time today REDWOOD CITY, Calif., March 03, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces financial results for the three and 12 months ended December 31, 2015, provides an update on the company's business progress and introduces 2016 financial guidance. “The fourth quarter marks the highest quarterly product revenues from o... 
March 03, 2016
Codexis Adds Life Sciences Industry Veteran David V. Smith to Its Board of Directors
REDWOOD CITY, Calif., March 03, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, announces the appointment of David V. Smith to its Board of Directors, increasing the size of the Board to nine Directors. He brings to Codexis more than 30 years of financial and operational management experience that includes senior executive positions in multibillion-dollar life sciences companies. “David’s impressi... 
February 25, 2016
Codexis to Hold 2015 Fourth Quarter and Full Year Conference Call on March 3
REDWOOD CITY, Calif., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report fourth quarter and full year 2015 financial results after market close on Thursday, March 3, 2016.  Codexis management will hold an investment community conference call at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss financial results and provide a company update.        Live Call: U.S. ... 
February 22, 2016
Codexis Files Lawsuit against EnzymeWorks and CEO Junhua “Alex” Tao for Patent Infringement and Misappropriation of Trade Secrets
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Feb. 22, 2016-- Codexis, Inc. (Nasdaq: CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, announces the filing of a lawsuit against EnzymeWorks and its founder, Junhua “Alex” Tao, for willful patent infringement, misappropriation of trade secrets, breach of confidence, and other claims. The suit was filed as Case No. 3:16-cv-00826-BLF in the United States District Court, ... 

Sign up for E-mail Alerts

You may automatically receive Codexis, Inc. information by e-mail




Enter your e-mail address here:
Print Page Print Page | E-mail Page E-mail Page |

Share Page

X
| Financial Tear Sheet Tear Sheet

WE ARE BIOCATALYSIS®

We are an industrial biotechnology company providing unique, state-of-the-art enzyme optmization services and biocatalyst products.


BIOCATALYSIS PRODUCTS

Codexis offers complete biocatalysis solutions from “off-the-shelf” enzymes and Screening Kits, to commercial supply of biocatalysts.

CODEXIS

CODEEVOLVER®


Our protein engineering technology enables the rapid development of custom-designed enzymes

CODEXIS

MEDIA CENTER


Visit our Media Center for the latest press information, videos, imagery, and technical papers.

CAREERS AT CODEXIS

Continued success at Codexis depends on the innovation, collaboration and commitment of people who are passionate about what they do


CODEXIS

INVESTOR CENTER


Access to Codexis information for the investment community


built@zoomedia
You are now leaving this website. If you would like to continue, click Continue.
CancelContinue